Neurological symptoms in patients after the novel coronavirus infection COVID-19, determining further rehabilitation strategy

Abstract

Since the Spanish flu in 1918, there has not been such a large-scale pandemic, causing significant damage to the economy of Russia and other countries, as the novel coronavirus infection COVID-19, which began in December 2019. The SARS-CoV-2 virus is highly infectious and can proceed both asymptomatic and in an extremely severe form, especially in the presence of comorbidity. Despite the fact that the clinical picture is associated with respiratory syndrome, long-term neurological symptoms are increasingly observed. In this study, we tried to find out the most pronounced and long-lasting neurological symptoms in the first 6 months after the novel coronavirus infection COVID-19. An important role in the rehabilitation process of this group of patients is played by the strategy of neurocytoprotection, which is aimed at preventing and reducing neuronal damage by affecting the cellular mechanisms of neuroregeneration and cerebral reorganization, which leads not only to structural and metabolic, but also to functional recovery.